ArticleJournal of pharmacy & bioallied sciences2025
Assessment of Implant Success in Patients with Immunocompromised Conditions: An Original Research.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Viral Contributions to Periodontal and Peri-implant Disease: A Narrative Review.Saudi journal of medicine & medical sciencesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to evaluate the success of dental implants in immunocompromised patients, assessing factors such as osseointegration, peri-implant tissue health, and overall survival rates. Methods: A retrospective cohort study was conducted on 60 immunocompromised patients who received dental implants between 2018 and 2022. Key metrics such as implant survival, marginal bone loss, and peri-implantitis prevalence were assessed over a 3-year follow-up. Results: The overall implant survival rate was 88.5%, with no statistically significant differences across subgroups of immunocompromised conditions. Marginal bone loss averaged 1.2 mm, with peri-implantitis occurring in 15% of cases. Conclusions: Despite underlying conditions, dental implants demonstrate a relatively high success rate in immunocompromised patients, contingent on rigorous preoperative planning and postoperative care. Clinical Relevance: This study underscores the viability of dental implants in patients with systemic health challenges, offering insights into tailored implant care protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.